These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2400725)

  • 61. [Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology].
    Stella F; Alfani D; Stella C; Battistelli S; Troccoli R; Cortesini R
    Quad Sclavo Diagn; 1985 Sep; 21(3):330-40. PubMed ID: 3915106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
    Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
    Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Melanoma in organ transplant patients].
    Lévêque L; Dalac S; Dompmartin A; Louvet S; Euvrard S; Catteau B; Hazan M; Schollhamer M; Aubin F; Dreno B; Daguin P; Chevrant-Breton J; Frances C; Bismuth MJ; Tanter Y; Lambert D
    Ann Dermatol Venereol; 2000 Feb; 127(2):160-5. PubMed ID: 10739973
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Pseudolymphoma induced by cyclosporin].
    Bagot M; Wechsler J; Perrussel M; Robbiola O; Debure C; Dubertret L
    Ann Dermatol Venereol; 1989; 116(11):894-6. PubMed ID: 2619199
    [No Abstract]   [Full Text] [Related]  

  • 65. [Spontaneous manifestation and regression of a Kaposi's sarcoma under cyclosporin A therapy].
    Pilgrim M
    Hautarzt; 1988 Jun; 39(6):368-70. PubMed ID: 3042706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Evaluation of premalignant and malignant lesions during the induction of mouse melanomas.
    Berkelhammer J; Oxenhandler RW
    Cancer Res; 1987 Mar; 47(5):1251-4. PubMed ID: 3102042
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cyclosporin A in systemic sclerosis.
    Zachariae H; Zachariae E
    Br J Dermatol; 1987 May; 116(5):741-2. PubMed ID: 3593641
    [No Abstract]   [Full Text] [Related]  

  • 68. Levodopa therapy and malignant melanoma.
    Sober AJ; Wick MM
    JAMA; 1978 Aug; 240(6):554-5. PubMed ID: 671667
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduced erythrocyte and leukocyte magnesium is associated with cyclosporin treatment and hypertension in renal transplant patients.
    al-Khursany I; Thomas TH; Harrison K; Wilkinson R
    Nephrol Dial Transplant; 1992; 7(3):251-5. PubMed ID: 1314999
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Targeted blood levels of cyclosporin for cardiac transplantation.
    Griffith BP; Hardesty RL; Trento A; Lee A; Bahnson HT
    J Thorac Cardiovasc Surg; 1984 Dec; 88(6):952-7. PubMed ID: 6389991
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immediate post-transplant renal failure: evidence for an immunologic pathogenesis.
    Lipkowitz GS; Hong JH; Galishoff ML; McMillen M; Sumrani N; Hanson P; Tejani A; Butt KM
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1256-7. PubMed ID: 2652413
    [No Abstract]   [Full Text] [Related]  

  • 72. [Use of cyclosporin A after antilymphocyte serum in renal transplantation].
    Hourmant M; Soulillou JP; Remi JP; Sagniez G; Guenel J
    Presse Med; 1985 Nov; 14(41):2093-6. PubMed ID: 2934708
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Differentiation between allograft rejection and cyclosporin nephrotoxicity in renal-transplant recipients.
    Taube DH; Neild GH; Williams DG; Cameron JS; Hartley B; Ogg CS; Rudge CJ; Welsh KI
    Lancet; 1985 Jul; 2(8448):171-4. PubMed ID: 2862369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triple therapy and initial renal graft perfusion.
    Thomsen HS; Nielsen SL
    Dan Med Bull; 1988 Aug; 35(4):393-5. PubMed ID: 3048925
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Squamous-cell epitheliomata and cyclosporine treatment.
    Bencini PL; Montagnino G; Crosti C; Sala F
    Br J Dermatol; 1985 Sep; 113(3):373-4. PubMed ID: 3904807
    [No Abstract]   [Full Text] [Related]  

  • 76. Cyclosporin A treatment of systemic sclerosis.
    Zachariae H; Halkier-Sørensen L; Heickendorff L; Zachariae E; Hansen HE
    Br J Dermatol; 1990 May; 122(5):677-81. PubMed ID: 2354119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Successful cyclosporin therapy of acquired hemophilia caused by factor VIII (VIII:C) inhibiting antibody].
    Pfliegler G; Boda Z; Hársfalvi J; Flóra-Nagy M; Sári B; Pecze K; Rák K
    Orv Hetil; 1991 Jul; 132(27):1485-8. PubMed ID: 1956679
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pituitary-testicular axis in patients with transplanted kidney treated with cyclosporin with prednisone or azathioprine with prednisone].
    Nieszporek T; Grzeszczak W; Kokot F; Zukowska-Szczechowska E; Kuśmierski S; Kurzbauer R; Szkodny A
    Pol Tyg Lek; 1988 Apr; 43(15):478-82. PubMed ID: 3043393
    [No Abstract]   [Full Text] [Related]  

  • 79. Cortical blindness due to cyclosporin.
    Van Leeuwen ML; Van Gelder T; Van Gemert HM; Weimar W
    Neth J Med; 1993 Aug; 43(1-2):69-70. PubMed ID: 8232697
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Success of prednisone in the treatment of a patient with sarcoidosis and systemic sclerosis: Report of a case.
    Borges da Costa J; Mayer-da-Silva A; Soares de Almeida LM; Marques Gomes M
    Dermatol Online J; 2009 Mar; 15(3):11. PubMed ID: 19379655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.